Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
NCT00404482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2009-06-03
Summary
Juvenile idiopathic arthritis (JIA) is often associated with chronic anterior uveitis. Presence of vision threatening complications may indicate immunosuppressive therapy. In this study, the experience with cyclosporine A (CsA) as mono- or combination-therapy is analyzed.
Conditions
- Uveitis
- Juvenile Idiopathic Arthritis
Interventions
- DRUG
-
Cyclosporine A
Sponsors & Collaborators
-
St. Franziskus Hospital
lead OTHER
Principal Investigators
-
Christoph Tappeiner, MD · Department of Ophthalmology at University Bern - Inselspital
Eligibility
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-01-31
- Completion
- 2006-08-31
Countries
- Germany
Study Locations
More Related Trials
-
Cyclosporine Adverse Outcomes in Steroid Dependent and Frequent Relapsing Nephrotic Syndrome in Children;Single Center Study
NCT05588869 ·Status: UNKNOWN
-
Relevance and Efficiency of SecOnd Line Workup for Uveitis
NCT06102408 ·Status: NOT_YET_RECRUITING
-
The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular Leakage
NCT05015335 ·Status: UNKNOWN ·Phase: PHASE4
-
38 Week Extension Study to CAIN457C2303
NCT01093846 ·Status: TERMINATED ·Phase: PHASE3
-
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
NCT00647166 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
NCT06273748 ·Status: RECRUITING
-
Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
NCT00991146 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Cyclosporin in Nephrotic Syndrome
NCT01616446 ·Status: COMPLETED
-
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
NCT05767047 ·Status: RECRUITING ·Phase: PHASE3
-
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
NCT06611696 ·Status: RECRUITING ·Phase: PHASE4
-
NUCALA® Special Drug Use Investigation (EGPA, Long-term)
NCT03557060 ·Status: COMPLETED
-
Phase III Study in Refractory Behcet's Disease
NCT00995709 ·Status: COMPLETED ·Phase: PHASE3
-
Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
NCT00770601 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT01302860 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose Glucocorticoid Vasculitis Induction Study
NCT02198248 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
NCT04889430 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020
NCT05370690 ·Status: UNKNOWN
-
A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy
NCT02173106 ·Status: UNKNOWN ·Phase: PHASE2
-
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
NCT01730495 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease
NCT00841789 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
NCT02291029 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
NCT04817618 ·Status: RECRUITING ·Phase: PHASE3
-
Multi-model Image of Immunosuppressive Agents in TAO
NCT05110040 ·Status: RECRUITING ·Phase: NA